Terbinafine + Terbinafine Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Tinea Pedis
Conditions
Tinea Pedis
Trial Timeline
Aug 1, 2011 → Feb 1, 2012
NCT ID
NCT01433107About Terbinafine + Terbinafine Placebo
Terbinafine + Terbinafine Placebo is a phase 3 stage product being developed by Novartis for Tinea Pedis. The current trial status is completed. This product is registered under clinical trial identifier NCT01433107. Target conditions include Tinea Pedis.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01433107 | Phase 3 | Completed |
Competing Products
20 competing products in Tinea Pedis